Evidence map›Paper›PMID 39156042›Full record

GuidelineFarmaceuticos comunitarios2024

[Recommendations for the prevention of healthcare-associated infections in nursing homes].

E Bouza, A Asensio, J García Navarro, P González, M Acosta Benito, J Aguilar, J Barberán, J Cabrera, J Díez-Manglano, C Fernández and 8 more

Abstract readEnglish AbstractPractice Guideline
In one paragraph

Guideline in Farmaceuticos comunitarios, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. [Recommendations on prevention and treatment of respiratory infections in institutionalised older people].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

E BouzaCIBER de Enfermedades Respiratorias (CIBERES CB06/06/0058), España. Patrono de la Fundación de Ciencias de la Salud. Servicio de Microbiología y Enfermedades Infecciosas Hospital General Universitario Gregorio Marañón. Catedrático de Medicina. Universidad Complutense. Madrid. Universidad Complutense España.
A AsensioJefe del servicio de Medicina Preventiva del Hospital Universitario Puerta de Hierro-Majadahonda, Madrid. Hospital Universitario Puerta de Hierro España.
J García NavarroGeriatra, Presidente de la Sociedad Española de Geriatría y Gerontología. Sociedad Española de Geriatría y Gerontología España.
P GonzálezGeriatra, Director Médico Residencia Los Nogales-Pacífico, Madrid. Residencia Los Nogales-Pacífico España.
M Acosta BenitoMiembro del GdT Atención al Mayor de semFYC y coordinador del GdT Prevención en el Anciano del PAPPS. semFYC España.
J AguilarPresidente, Consejo General de Colegios Oficiales de Farmacéuticos Consejo General de Colegios Oficiales de Farmacéuticos España.
J BarberánMicrobiólogo, Presidente Sociedad Española de Quimioterapia (SEQ). Sociedad Española de Quimioterapia España.
J CabreraMédico de Familia. GdT IMVAP - Infecciosas, Migrante, Vacunas y Actividades Preventivas. Sociedad Española de Médicos de Atención Primaria (SEMERGEN). Sociedad Española de Médicos de Atención Primaria España.
J Díez-ManglanoSociedad Española de Medicina Interna (SEMI). Sociedad Española de Medicina Interna España.
C FernándezResponsable de Divulgación Científica, Consejo General de Colegios Oficiales de Farmacéuticos Consejo General de Colegios Oficiales de Farmacéuticos España.
M Fernandez-PradaSecretaria, Asociación Española de Vacunología (AEV). Asociación Española de Vacunología España.
G FontánCoordinadora Instituto Español de Investigación Enfermera. Consejo General de Enfermería de España (CGE). Consejo General de Enfermería de España España.
J CisnerosSociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica España.
B Lorenzo-VidalSociedad Española de Médicos Generales y de Familia (SEMG). Sociedad Española de Médicos Generales y de Familia España.
A Martín OliverosDra. en Farmacia. Graduada en Nutrición Humana y Dietética. Vocal Junta Directiva de la Sociedad Española de Farmacia Clínica, Familiar y Comunitaria (SEFAC). Patrono de la Fundación SEFAC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria España.
P NavasSociedad Española de Medicina Preventiva, Salud Pública y Gestión Sanitaria (SEMPSPH). Sociedad Española de Medicina Preventiva, Salud Pública y Gestión Sanitaria España.
E PalomoDoctor en Farmacia. Director Fundación de Ciencias de la Salud. Fundación de Ciencias de la Salud. España.
M KestlerMédico Adjunto, Servicio de Microbiología Clínica y E. Infecciosas, Hospital Gregorio Marañón, Madrid. Profesora Asociada. Facultad de Medicina. U. Complutense Hospital Gregorio Marañón España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nursing homes (NH) although conceptually they should look as much like a home as possible, NH have unquestionable similarities with a nosocomium as they are places where many patients with underlying diseases and comorbidities accumulate and where the transmission of microorganisms between residents and between residents and caregivers is frequent.We have not found any recommendations specifically aimed at the prevention of nosocomial infections in MRI by the major Public Health Agencies and, therefore, the Health Sciences Foundation (Fundación de Ciencias de la Salud) has convened a series of experts and 14 Spanish scientific societies to discuss recommendations that could guide NH personnel in establishing written programs for the control and reduction of these infections. The present document is the result of these deliberations and contains suggestions for establishing such control programs on a voluntary and flexible basis in NH. We also hope that the document can help the health authorities to encourage this control activity in the different territorial areas of Spain. In our opinion, it is necessary to draw up a written plan and establish the figure of a coordinator or person responsible for implementing these projects. The document includes measures to be implemented and ways of quantifying the reality of different problems and of monitoring the impact of the measures established.

Indexed as

Cross InfectionNursing HomesHumansInfection ControlSpainenvironmental hygiene measuresincentive to use vaccinesnosocomial infectionnursing homesprimary preventionRespiratory infectionskin and soft tissue infectionurinary tract infection

Identifiers

PMID39156042
PMCPMC11326686

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.